MARKET

TIVC

TIVC

Tivic Health Systems Inc
NASDAQ
2.040
+0.270
+15.25%
Closed 19:59 12/04 EST
OPEN
1.850
PREV CLOSE
1.770
HIGH
2.227
LOW
1.850
VOLUME
206.38K
TURNOVER
23.43K
52 WEEK HIGH
15.64
52 WEEK LOW
1.470
MARKET CAP
3.60M
P/E (TTM)
-0.2066
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at TIVC last week (1124-1128)?
Weekly Report · 4d ago
Weekly Report: what happened at TIVC last week (1117-1121)?
Weekly Report · 11/24 09:39
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 11/18 17:06
Tivic Health secures BARDA meeting for entolimod in ARS
TipRanks · 11/18 15:10
Tivic Health Systems Secures Techwatch Meeting With Biomedical Advanced Research and Development Authority's Radiological and Nuclear Medical Countermeasures Program Staff For for Acute Radiation Syndrome
Benzinga · 11/18 13:35
Weekly Report: what happened at TIVC last week (1110-1114)?
Weekly Report · 11/17 09:39
Tivic Health’s Earnings Call: Strategic Shift and Challenges
TipRanks · 11/16 00:07
Tivic Health Systems Advances Biologics Pipeline
TipRanks · 11/15 03:59
More
About TIVC
Tivic Health Systems, Inc. is a diversified therapeutics company, with complementary bioelectronic and biologic product candidates in its clinical pipeline. It harnesses the power of the immune and autonomic nervous systems to fight disease and restore health. It takes a multi-pronged approach to treating diseases caused by immune dysregulation and dysautonomia. The complement of bioelectronic and biologic medicines allows it to target disorders and disease via both neural pathways and molecular approaches. Its commercial product, ClearUP, is clinically proven to treat sinus pain and pressure. ClearUP is available through online retailers and commercial distributors. It also has worldwide exclusive license rights to the late-stage Toll-like Receptor 5 (TLR5) agonist Entolimod for the treatment of acute radiation syndrome (ARS). In addition, it has an exclusive option to license five additional indications and clinical use cases for Entolimod and its derivative, Entalasta.

Webull offers Tivic Health Systems Inc stock information, including NASDAQ: TIVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TIVC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading TIVC stock methods without spending real money on the virtual paper trading platform.